skip to Main Content
BCBS Horizon Medical Policy Updates – September 2018

BCBS Horizon Medical Policy Updates – September 2018

Click here to view the Blue Cross Blue Shield Horizon Medical Policy Updates »

September 2018 Medical Policy Updates:

  • Ablation Procedures for Peripheral Neuromas
  • Actigraphy
  • Agalsidase Beta (Fabrazyme)
  • Alcohol Injections for Treatment of Peripheral Neuromas
  • Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry
  • Arthroscopy for Treatment of Knee Derangement
  • Automated Point-of-Care Nerve Conduction Tests
  • Autonomic Nervous System Testing
  • Belimumab (Benlysta)
  • Bronchial Thermoplasty
  • Bronchial Valves
  • Chemonucleolysis
  • Colon Hydrotherapy
  • Cosmetic Procedures
  • Cupping Therapy
  • Drug Therapy for Hereditary Angioedema [Cinryze Berinert Haegarda (Human C1 Inhibitor) Kalbitor (Ecallantide) Firazyr (Icatibant) Ruconest (C1 Esterase Inhibitor [Recombinant])]
  • Eculizumab (Soliris)
  • Electromagnetic Navigation Bronchoscopy
  • Electronic Salivary Reflex Stimulator
  • Epidural Spinal Endoscopy
  • Extracorporeal Shock Wave Treatment for Plantar Fasciitis and Other Musculoskeletal Conditions
  • Fluency Enhancing Devices for Stuttering
  • Gait Trainers and Standing Frames
  • Gaucher Disease Therapy
  • Gender Reassignment Surgery
  • Genetic Cancer Susceptibility Panels Using Next Generation Sequencing
  • Heart Rate Variability Measurement
  • Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
  • Home Traction Devices for the Treatment of Spinal Disorders and Pain
  • Hyperbaric Oxygen Therapy
  • Immune Globulin Subcutaneous (Vivaglobin Hizentra Gammagard Liquid Gamunex-C or Gammaked HyQvia and Cuvitru for Subcutaneous Administration)
  • In Vitro Chemosensitivity and Chemoresistance Assays
  • Interferential Current Stimulation
  • Intermittent Pneumatic or Mechanical Compression Devices for Peripheral Artery Disease
  • Intravenous Immunoglobulin (IVIG) Therapy
  • Laronidase (Aldurazyme) Galsulfase (Naglazyme) and Idursulfase (Elaprase) elosulfase alfa (Vimizim) and vestronidase alfa (Mepsevii)
  • Low-Level Laser Therapy
  • Magnetic Resonance-Guided Focused Ultrasound
  • Melphalan (Alkeran and Evomela)
  • Navigated Transcranial Magnetic Stimulation
  • Neurofeedback
  • Paraspinal Surface Electromyography (SEMG) to Evaluate and Monitor Back Pain
  • Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux (VUR)
  • Polysomnography for NonRespiratory Sleep Disorders
  • Pompe Disease Treatment with Myozyme (Alglucosidase alfa) and Lumizyme (Alglucosidase alfa)
  • Quantitative Sensory Testing
  • Removal of Benign Skin Lesions
  • Rhinoplasty
  • Salivary Hormone Testing for Menopause
  • Seat Lift Mechanisms
  • Site of Service for Administration for Infusion and Injectable Prescription Medications
  • Thoracic-Lumbo-Sacral Orthosis with Pneumatics
  • Treatment of Tinnitus

Added 9/18/2018;

  • Ablation Procedures for Peripheral Neuromas
  • Alcohol Injections for Treatment of Peripheral Neuromas
  • Angiogenic Inhibitors for the Treatment of Ophthalmic Macular Conditions
  • Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions
  • Automated Point-of-Care Nerve Conduction Tests
  • Autonomic Nervous System Testing
  • BRAF Gene Mutation Testing To Select Melanoma or Glioma Patients for Targeted Therapy
  • Bronchial Thermoplasty
  • Bronchial Valves
  • Compression Stockings
  • Continuous or Intermittent Monitoring of Glucose in the Interstitial Fluid
  • Cranial Electrotherapy Stimulation and Auricular Electrostimulation
  • Cryosurgical Ablation of Miscellaneous Solid Tumors Other Than Liver Prostate or Dermatologic Tumors
  • Cytochrome P450 Genotype-Guided Treatment Strategy
  • Diagnosis and Medical Management of Obstructive Sleep Apnea Syndrome
  • Electromagnetic Navigation Bronchoscopy
  • Electromyography and Nerve Conduction Studies
  • Electronic Brachytherapy for Nonmelanoma Skin Cancer
  • Electrotherapies in Pain Management
  • Extracorporeal Shock Wave Treatment for Plantar Fasciitis and Other Musculoskeletal Conditions
  • Fecal Calprotectin Testing
  • Gender Reassignment Surgery
  • Gene Expression Profiling for Uveal Melanoma
  • Genetic Testing for Diagnosis and Management of Mental Health Conditions
  • Genetic Testing for Mitochondrial Disorders
  • Genotype-Guided Warfarin Dosing
  • Home Cardiorespiratory Monitoring
  • Interferential Current Stimulation
  • Interspinous and Interlaminar Stabilization or Distraction Devices (Spacers)
  • JAK2 MPL and CALR Testing for Myeloproliferative Neoplasms
  • Low-Level Laser Therapy
  • Lumbar Spinal Fusion
  • Lung Volume Reduction Surgery for Severe Emphysema
  • Molecular Markers in Fine Needle Aspirates of the Thyroid
  • Myoelectric Prosthetic and Orthotic Components for the Upper Limb
  • Noninvasive Prenatal Screening for Fetal Aneuploidies and Microdeletions Using Cell-Free Fetal DNA
  • Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Disorders
  • Polysomnography for NonRespiratory Sleep Disorders
  • Prostatic Urethral Lift
  • Proton Beam Therapy
  • Quantitative Sensory Testing
  • Radioembolization for Primary and Metastatic Tumors of the Liver
  • Refractive Keratoplasty Procedures
  • Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases
  • Sodium Hyaluronate Injections
  • Transcatheter Arterial Chemoembolization To Treat Primary or Metastatic Liver Malignancies
  • Treatment of Varicose Veins or Venous Insufficiency
  • Tumor-Treatment Fields Therapy

Added 9/27/2018;

  • Abdominoplasty
  • Allergen Immunotherapy
  • Antineoplaston Therapy
  • Cryosurgical Ablation of Primary or Metastatic Liver Tumors
  • Donor Lymphocyte Infusion for Malignancies Treated with an Allogeneic Hematopoietic Stem-Cell Transplant
  • Endobronchial Brachytherapy
  • Genetic Testing for Li-Fraumeni Syndrome
  • Home Uterine Activity Monitoring (HUAM)
  • Insulin Infusion Pumps
  • Intracavitary Balloon Catheter Brain Brachytherapy for Malignant Gliomas or Metastasis to the Brain
  • Ipilimumab (Yervoy)
  • KRAS NRAS and BRAF Variant Analysis in Metastatic Colorectal Cancer
  • Mechanical Stretching Devices for Limited Jaw Mobility
  • Miscellaneous Genetic and Molecular Diagnostic Tests
  • Moderate Penetrance Variants Associated with Breast Cancer in Individuals at High Breast Cancer Risk
  • Optical Coherence Tomography for Imaging of Coronary Arteries
  • Physician Standby Service
  • Plasma Exchange
  • Prophylactic Oophorectomy
  • Radiofrequency Ablation of Primary or Metastatic Liver Tumors
  • Septoplasty
  • Surgical Interruption of Pelvic Nerve Pathways for Primary and Secondary Dysmenorrhea
  • Threshold Electrical Stimulation as a Treatment of Motor Disorders


Click here to view the Blue Cross Blue Shield Horizon Medical Policy Updates »


Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top